Administration of the CCSG is consolidated in the Office of Translational Research under the direction of the CCSG Co-PI, Dr. Robert Bast, who reports to the Pl, Dr. Ronald DePinho, for matters relating to the CCSG. Administrative support is provided in the following areas: (1) business operations and financial management of shared resources;(2) central organization and coordination for the scientific and technical aspects of shared resource operations;(3) facilitation of programmatic interactions and engagement;(4) facilitation of communication between center director, program leaders, shared resource directors, and program members;(5) development, management, and maintenance of databases for program funding, program membership, program member publications, program member biographical information, and shared resource utilization;(6) allocation and monitoring of the use of CCSG development funds;(7) coordination and writing of CCSG progress reports and competitive renewal applications;(8) organization of CCSG Executive Committee and annual External Advisory Board meetings. The 5 administrative staff supporting the CCSG have extensive scientific, management, and administrative skills and experience. Alan McClelland, PhD, is responsible for analysis, planning and facilitation of all CCSG funded activities and reports directly to Dr. Bast. Dr. McClelland manages, directs, and oversees the overall administration of the CCSG award. Katherine Stemke Hale, PhD, is responsible for scientific, technical, and operational oversight, coordination and strategic planning for all institutional shared resources. Holly Stephenson maintains program membership data, assigns grant funding to programs as directed by the Pl, prepares and submits progress reports and cancer center summaries, organizes the logistics of external advisory board visits, and provides administrative support for the preparation of the CCSG competitive renewal application. Audrey Jones is responsible for managing all aspects of CCSG finances, including budgeting, allocation, monitoring, and reporting for all sources of funds that support CCSG-funded infrastructure, including shared resources. Carolyn Duff works with the Faculty Information System (PIS), a database system used for CCSG publication data management and reporting, and is also responsible for updating MD Anderson internal and external websites for CCSG programs and shared resource content.

Public Health Relevance

Personnel in the Office of Translational Research provide administrative support and assistance to the cancer center director, senior leadership, program leaders, shared resource directors, and the cancer center members to facilitate their access to research resources and to ensure accountability and stewardship of CCSG-funded research resources.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016672-39
Application #
8759810
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2014-07-01
Budget End
2015-06-30
Support Year
39
Fiscal Year
2014
Total Cost
$535,694
Indirect Cost
$201,025
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
800772139
City
Houston
State
TX
Country
United States
Zip Code
77030
Reddy, S M; Barcenas, C H; Sinha, A K et al. (2018) Long-term survival outcomes of triple-receptor negative breast cancer survivors who are disease free at 5 years and relationship with low hormone receptor positivity. Br J Cancer 118:17-23
Reyes-Gibby, Cielito C; Wang, Jian; Yeung, Sai-Ching J et al. (2018) Genome-wide association study identifies genes associated with neuropathy in patients with head and neck cancer. Sci Rep 8:8789
Roland, Christina L; Bednarski, Brian K; Watson, Kelsey et al. (2018) Identification of preoperative factors associated with outcomes following surgical management of intra-abdominal recurrent or metastatic GIST following neoadjuvant tyrosine kinase inhibitor therapy. J Surg Oncol 117:879-885
Gulhati, Pat; Raghav, Kanwal; Shroff, Rachna et al. (2018) Phase II Study of Panitumumab in RAS Wild-Type Metastatic Adenocarcinoma of Small Bowel or Ampulla of Vater. Oncologist 23:277-e26
Bhattacharya, Rajat; Ellis, Lee M (2018) It Is Time to Re-Evaluate the Peer Review Process for Preclinical Research. Bioessays 40:
Boddu, Prajwal; Oviedo, Sergio Pina; Rausch, Caitlin R et al. (2018) PET-CT in AML-related hemophagocytic lymphohistiocytosis. Leuk Lymphoma 59:1486-1489
Assi, Rita; Garcia-Manero, Guillermo; Ravandi, Farhad et al. (2018) Addition of eltrombopag to immunosuppressive therapy in patients with newly diagnosed aplastic anemia. Cancer 124:4192-4201
Alhuraiji, Ahmad; Kantarjian, Hagop; Boddu, Prajwal et al. (2018) Prognostic significance of additional chromosomal abnormalities at the time of diagnosis in patients with chronic myeloid leukemia treated with frontline tyrosine kinase inhibitors. Am J Hematol 93:84-90
Luo, Yangkun; Xu, Yujin; Liao, Zhongxing et al. (2018) Automatic segmentation of cardiac substructures from noncontrast CT images: accurate enough for dosimetric analysis? Acta Oncol :1-7
Zhao, Na; Cao, Jin; Xu, Longyong et al. (2018) Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancer. J Clin Invest 128:1283-1299

Showing the most recent 10 out of 12418 publications